An international team, involving researchers from Hospital Clínic-IDIBAPS and the Multiple Sclerosis Centre of Catalonia (Cemcat), has identified for the first time a genetic variant related to the progression of multiple sclerosis. It is located near two genes that had not previously been linked to multiple sclerosis. According to Stephen Sawcer, co-lead author of the study, "understanding how the variant exerts its effects on the severity of multiple sclerosis will pave the way for a new generation of treatments that can prevent disease progression". The results are published in the journal Nature.
Neurologist specialising in autoimmune and neuromuscular neurological diseases at the Hospital Sant Pau in Barcelona.